Quadrise Fuels International test results for bioMSAR exceeded expectations (LON:QFI) 7 September 2021
Arbuthnot Banking Group: Hardman & Co “expecting accelerated profit growth” (LON:ARBB) 3 September 2021
Real Estate Credit Investments “continued delivery of steady returns” says Hardman & Co (LON:RECI) 3 September 2021
Kenmare Resources could see enhanced overall returns to shareholders in coming periods (LON:KMR) 3 September 2021
CyanConnode Q&A: African partnerships to be a significant driver for medium-term growth (LON:CYAN) 26 August 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Cranswick PLC (CWK.L) Stock Analysis: Exploring a 14.75% Potential Upside in the Defensive Food Sector 21 January 2026
Computacenter PLC (CCC.L) Stock Analysis: Navigating a 4.27% Upside Potential with Robust Growth and Dividend Appeal 21 January 2026
Chrysalis Investments Limited (CHRY.L) Stock Analysis: Unlocking a 28.75% Potential Upside with Strong Buy Ratings 21 January 2026
Coats Group PLC (COA.L) Stock Analysis: Unpacking a 40.78% Potential Upside for Investors 21 January 2026
Quadrise Fuels International test results for bioMSAR exceeded expectations (LON:QFI) 7 September 2021
Arbuthnot Banking Group: Hardman & Co “expecting accelerated profit growth” (LON:ARBB) 3 September 2021
Real Estate Credit Investments “continued delivery of steady returns” says Hardman & Co (LON:RECI) 3 September 2021
Kenmare Resources could see enhanced overall returns to shareholders in coming periods (LON:KMR) 3 September 2021
CyanConnode Q&A: African partnerships to be a significant driver for medium-term growth (LON:CYAN) 26 August 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Cranswick PLC (CWK.L) Stock Analysis: Exploring a 14.75% Potential Upside in the Defensive Food Sector 21 January 2026
Computacenter PLC (CCC.L) Stock Analysis: Navigating a 4.27% Upside Potential with Robust Growth and Dividend Appeal 21 January 2026
Chrysalis Investments Limited (CHRY.L) Stock Analysis: Unlocking a 28.75% Potential Upside with Strong Buy Ratings 21 January 2026
Coats Group PLC (COA.L) Stock Analysis: Unpacking a 40.78% Potential Upside for Investors 21 January 2026
Kestra Medical Technologies (KMTS): Investor Outlook with a 53.4% Revenue Growth Amid a Promising Upside 16 December 2025
Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating a Challenging Landscape with Potential Upside 16 December 2025
Mineralys Therapeutics, Inc. (MLYS) Investor Outlook: A 37.77% Potential Upside in Biotechnology 16 December 2025
Disc Medicine, Inc. (IRON) Stock Analysis: A Promising 30% Upside in the Biotech Sector 16 December 2025
Dyne Therapeutics Inc. (DYN) Stock Analysis: Unpacking a Potential 98% Upside in Biotech Innovation 16 December 2025
89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 104.68% Upside in the Biotech Arena 16 December 2025
Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 15% Potential Upside Amidst Mixed Financial Metrics 16 December 2025
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Assessing a 25.25% Potential Upside in the Medical Instruments Sector 16 December 2025
CG Oncology, Inc. (CGON) Stock Analysis: A 77.90% Potential Upside with Promising Clinical Trials 16 December 2025
Denali Therapeutics (DNLI) Rating Update: Exploring an 85% Potential Upside in Neurodegenerative Treatments 16 December 2025
Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: A Compelling 59% Potential Upside in the Biotech Sector 16 December 2025
Harrow, Inc. (HROW) Stock Analysis: A 54.54% Potential Upside Ignites Investor Interest 16 December 2025
Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a Promising 44% Upside in Biotech Innovation 16 December 2025
Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating Growth with a 19.80% Upside Potential 16 December 2025
AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings Signal Potential 27.52% Upside for Investors 16 December 2025
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a 20.54% Potential Upside in the Healthcare Sector 16 December 2025
Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring the 11.37% Upside Potential 16 December 2025
Surface Transforms contracts are flowing with high profile manufacturers (Analyst Interview) 7 September 2021
Pantheon International 20% NAV growth; right place at right time (Analyst Interview) 3 September 2021
Admiral Group delivers strong H1 results, growing profits, revenues and customer numbers 15 August 2024
Aviva plc Reports Strong First Half of 2024, With Double-Digit Growth Across Key Metrics 14 August 2024
Quadrise Fuels International test results for bioMSAR exceeded expectations (LON:QFI) 7 September 2021
Arbuthnot Banking Group: Hardman & Co “expecting accelerated profit growth” (LON:ARBB) 3 September 2021
Real Estate Credit Investments “continued delivery of steady returns” says Hardman & Co (LON:RECI) 3 September 2021
Kenmare Resources could see enhanced overall returns to shareholders in coming periods (LON:KMR) 3 September 2021
CyanConnode Q&A: African partnerships to be a significant driver for medium-term growth (LON:CYAN) 26 August 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Cranswick PLC (CWK.L) Stock Analysis: Exploring a 14.75% Potential Upside in the Defensive Food Sector 21 January 2026
Computacenter PLC (CCC.L) Stock Analysis: Navigating a 4.27% Upside Potential with Robust Growth and Dividend Appeal 21 January 2026
Chrysalis Investments Limited (CHRY.L) Stock Analysis: Unlocking a 28.75% Potential Upside with Strong Buy Ratings 21 January 2026
Coats Group PLC (COA.L) Stock Analysis: Unpacking a 40.78% Potential Upside for Investors 21 January 2026
